Although a meta-analysis performed by Bai et al. [14] has shown that overexpression of S100A4 was associated with poor prognosis in lung cancer, the number of included studies was relatively small and the relationship between S100A4 expression and clinicopathological features in NSCLC was not investigated. This evidence concerns the gene S100A4 and lung cancer.